Correlation Between Acri Capital and LAVA Medtech
Can any of the company-specific risk be diversified away by investing in both Acri Capital and LAVA Medtech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acri Capital and LAVA Medtech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acri Capital Acquisition and LAVA Medtech Acquisition, you can compare the effects of market volatilities on Acri Capital and LAVA Medtech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acri Capital with a short position of LAVA Medtech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acri Capital and LAVA Medtech.
Diversification Opportunities for Acri Capital and LAVA Medtech
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Acri and LAVA is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Acri Capital Acquisition and LAVA Medtech Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LAVA Medtech Acquisition and Acri Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acri Capital Acquisition are associated (or correlated) with LAVA Medtech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LAVA Medtech Acquisition has no effect on the direction of Acri Capital i.e., Acri Capital and LAVA Medtech go up and down completely randomly.
Pair Corralation between Acri Capital and LAVA Medtech
If you would invest 1,044 in LAVA Medtech Acquisition on September 6, 2024 and sell it today you would earn a total of 0.00 from holding LAVA Medtech Acquisition or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 5.88% |
Values | Daily Returns |
Acri Capital Acquisition vs. LAVA Medtech Acquisition
Performance |
Timeline |
Acri Capital Acquisition |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
LAVA Medtech Acquisition |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Acri Capital and LAVA Medtech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Acri Capital and LAVA Medtech
The main advantage of trading using opposite Acri Capital and LAVA Medtech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acri Capital position performs unexpectedly, LAVA Medtech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LAVA Medtech will offset losses from the drop in LAVA Medtech's long position.The idea behind Acri Capital Acquisition and LAVA Medtech Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |